Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia
source: pixabay.com

Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia

Ana Pina from the Centro de Estudos de Doencas Cronicas at NOVA Medical School in Portugal, and her colleagues recently published an innovative study regarding the diagnosis of familial hypercholesterolemia (FH).…

Continue Reading Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia
Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
source: pixabay.com

Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases

Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…

Continue Reading Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
Presentation Highlights Need for Improvements in Familial Hypercholesterolemia Care
source: pixabay.com

Presentation Highlights Need for Improvements in Familial Hypercholesterolemia Care

According to a story from Healio, a recent presentation featured at the FH Foundation Global Summit was a stark reminder of the need for improved treatment for patients with familial…

Continue Reading Presentation Highlights Need for Improvements in Familial Hypercholesterolemia Care
This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
jarmoluk / Pixabay

This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?

According to a story from Forbes, a new drug developed by the company Regeneron has the potential to make a real difference for people with the homozygous form of familial…

Continue Reading This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
geralt / Pixabay

When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer

According to a story from FHM Pakistan, a recent study revealed the familial hypercholesterolemia patients are at a greater risk of stroke, heart attack, and other cardiovascular problems when they…

Continue Reading When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
katicaj / Pixabay

Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation

According to a story from bloomberg.com, the drug development company Arrowhead Pharmaceuticals, Inc. recently announced that its experimental product candidate AR0-ANG3 has earned Orphan Drug designation from the US Food…

Continue Reading Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
sabinurce / Pixabay

Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from brightsurf.com, familial hypercholesterolemia, a genetic condition that causes elevated levels of LDL cholesterol to appear at a young age, often goes undiagnosed. In fact, some…

Continue Reading Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from Healio, a recent study suggests that the addition of four more genes to the conventional genetic test used to diagnosed familial hypercholesterolemia could allow more…

Continue Reading Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

  Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…

Continue Reading Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia
New Cholesterol-Lowering Drug Could Provide Alternative to Statins
Statins May Do More Than Lower Cholesterol: They May Give IPF Drugs a Boost

New Cholesterol-Lowering Drug Could Provide Alternative to Statins

According to a publication from EurekAlert, high-cholesterol patients, who do not take statins (a type of cholesterol-lowering medication often prescribed by doctors) due to adverse side effects may benefit from…

Continue Reading New Cholesterol-Lowering Drug Could Provide Alternative to Statins

Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference

New Research to be Presented In just a few days the American College of Cardiology will host their 68th Annual Scientific Session (ACC.19). It will be held in New Orleans,…

Continue Reading Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference
Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases
stevepb / Pixabay

Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases

According to a story from Pharmaphorum, there are a number of new treatments that have been introduced or have seen major strides in development over the last year. More patient…

Continue Reading Patient Centricity Helps Facilitate The Introduction of New Therapies for Rare Diseases

2018 FH Global Summit Highlights

The 2018 FH Global Summit featured fantastic speakers, timely information, and valuable insight about the past, present and future of the way FH is understood, diagnosed, and managed. The summit…

Continue Reading 2018 FH Global Summit Highlights
New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program
QuinceMedia / Pixabay

New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

The Patient Advocate Foundation has recently begun to expand the reach of its popular Co-Pay Relief program. The Co-Pay Relief program is designed to provide financial assistance to qualifying patients.…

Continue Reading New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia

According to a story from the FH Foundation, the non-profit organization has released a vital consensus statement regarding the diagnosis of familial hypercholesterolemia, which is the most prevalent genetic cause…

Continue Reading New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia
New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
source: pixabay.com

New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia

According to a story from Cardiovascular Business, The FH Foundation, which is a frontrunning patient advocacy and research organization for familial hypercholesterolemia, recently announced that it has begun enrollment for…

Continue Reading New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
Close Menu